Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Ovid Therapeutics (OVID) Asset Utilization Ratio (2021 - 2026)

Ovid Therapeutics filings provide 6 years of Asset Utilization Ratio readings, the most recent being 0.04 for Q1 2026.

  • Quarterly Asset Utilization Ratio rose 499.91% to 0.04 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.04 through Mar 2026, up 499.91% year-over-year, with the annual reading at 0.06 for FY2025, 1144.87% up from the prior year.
  • Asset Utilization Ratio hit 0.04 in Q1 2026 for Ovid Therapeutics, down from 0.07 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.09 in Q3 2025 and bottomed at 0.0 in Q1 2023.
  • Average Asset Utilization Ratio over 5 years is 0.02, with a median of 0.01 recorded in 2022.
  • The largest annual shift saw Asset Utilization Ratio tumbled 99.5% in 2022 before it soared 1738.0% in 2025.
  • Ovid Therapeutics' Asset Utilization Ratio stood at 0.01 in 2022, then tumbled by 51.26% to 0.0 in 2023, then skyrocketed by 99.41% to 0.01 in 2024, then surged by 1062.2% to 0.07 in 2025, then tumbled by 43.98% to 0.04 in 2026.
  • Per Business Quant, the three most recent readings for OVID's Asset Utilization Ratio are 0.04 (Q1 2026), 0.07 (Q4 2025), and 0.09 (Q3 2025).